NCT06922578View on ClinicalTrials.gov

Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

June 1, 2026

Conditions
Pulpitis - Irreversible
Interventions
PROCEDURE

NeoPUTTY MTA pulpotomy

Neoputty MTA pulpotomy performed in vital primary molars with symptomatic irreversible pulpitis

PROCEDURE

Endoflas pulpectomy

Endoflas pulpectomy in vital primary molars with symptomatic irreversible pulpitis

All Listed Sponsors
lead

Cairo University

OTHER

NCT06922578 - Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter